Correlation of Staining for LKB1 and COX-2 in Hamartomatous Polyps and Carcinomas from Patients with Peutz Jeghers Syndrome
|
|
- Aubrey Garrison
- 6 years ago
- Views:
Transcription
1 Volume 51(12): , 2003 The Journal of Histochemistry & Cytochemistry ARTICLE Correlation of Staining for LKB1 and COX-2 in Hamartomatous Polyps and Carcinomas from Patients with Peutz Jeghers Syndrome Chongjuan Wei, Christopher I. Amos, Asif Rashid, Mahyar Sabripour, Linda Nations, Thomas J. McGarrity, and Marsha L. Frazier Departments of Epidemiology (CW,CIA,MS,LN,MLF) and Pathology (AR), University of Texas MD Anderson Cancer Center, Houston, Texas, and Department of Medicine (TJM), Milton S. Hershey Medical Center, Pennsylvania State University, Philadelphia, Pennsylvania SUMMARY Germline mutations of the LKB1 gene lead to Peutz Jeghers syndrome (PJS), which is associated with a predisposition to gastrointestinal polyposis and cancer. In this study we tested for germline mutations of LKB1 in 11 patients with PJS from nine families and analyzed the expression patterns of the LKB1 and cyclo-oxgenase-2 (COX-2) proteins in 28 Peutz Jeghers polyps (PJPs) and five carcinomas from these patients by immunohistochemical (IHC) analysis. In eight of those families we identified seven different mutations, which consisted of two splice site mutations, two nonsense mutations, one small inframe deletion, one frame-shift mutation, and one silent mutation. Immunostaining revealed nuclear and cytoplasmic expression of LKB1 protein in 23 PJPs and five carcinomas, nuclear expression alone in one PJP, and loss of LKB1 protein expression in four PJPs, indicating a heterogeneous LKB1 expression pattern in PJPs. Overexpression of COX-2 was detected in 23 (82%) of 28 PJPs and in all carcinomas. Despite heterogeneity in staining of LKB1 among individuals and even among samples from the same individual, we found statistically significant correlations in staining of LKB1 relative to COX-2. These results suggest that COX-2 plays a role in tumorigenesis in PJS and may therefore be considered as a potential target for PJS chemoprevention. (J Histochem Cytochem 51: , 2003) KEY WORDS Peutz Jeghers syndrome LKB1 COX-2 germline mutation immunohistochemistry Peutz Jeghers syndrome (PJS) is an autosomal dominant syndrome characterized by cutaneous hypermelanocytic macules and development of multiple gastrointestinal hamartomatous polyps (Jeghers et al. 1949; Foley et al. 1988). Patients with PJS also have a dramatically increased risk for development of a variety of neoplasias, including those of the small bowel, colon, pancreas, stomach, breast, and ovaries (Giardiello et al. 1987; Boardman et al. 1998; Spigelman et al. 1989). The genetic locus responsible for the majority of PJS cases was mapped to chromosome 19p13.3 and was found to encode a serine/threonine kinase Correspondence to: Marsha L. Frazier, Dept. of Epidemiology, Unit 189, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX mlfrazier@ mail.mdanderson.org Received for publication March 24, 2003; accepted August 13, 2003 (3A6052). named LKB1/STK11 (Hemminki et al. 1997,1998; Jenne et al. 1998). Various LKB1 gene mutations have been identified in patients with PJS, suggesting that LKB1 is a potential tumor suppressor gene. Although the mechanisms involved in the tumor suppressor function of LKB1 in PJS remain largely uncharacterized, several studies have suggested its roles in cell growth suppression and apoptosis. Reintroducing LKB1 into tumor cell lines that have lost LKB1 function leads to cycle arrest (Tiainen et al. 1999), and phosphorylation of LKB1 is essential for the cell growth suppression (Collins et al. 2000; Sapkota et al. 2001). LKB1 is involved in Brg-1-induced growth arrest and in mediating p53-dependent apoptosis (Karuman et al. 2001; Marignani et al. 2001). In addition, LKB1 mouse model studies demonstrated that heterozygous knockout mice developed gastrointestinal polyps that shared histological features with polyps found in hu- The Histochemical Society, Inc /03/$
2 1666 Wei, Amos, Rashid, Sabripour, Nations, McGarrity, Frazier man PJS (Bardeesy et al. 2002; Miyoshi et al. 2002; Rossi et al. 2002). Together, these data suggest that LKB1 plays an important role in tumorigenesis through either suppression of growth arrest or apoptosis. Cyclo-oxygenase (COX) is the rate-limiting enzyme in the formation of prostaglandins from arachidonic acid. COX exists in two isoforms, COX-1 and COX-2. COX-2 is constitutively absent in normal tissues but is rapidly induced by certain inflammatory cytokines, tumor promoters, growth factors, and oncogenes (Eberhart and DuBois 1995; Smith et al. 1996). Increased COX-2 levels have been identified in cancer of the colon, lung, breast, stomach, and prostate, and also in pancreatic adenocarcinomas (Prescott and Fitzpatrick 2000). Overexpression of COX-2 has been shown to result in resistance to apoptosis, modulation of adhesion of epithelial cells to the extracellular matrix, and promotion of angiogenesis. Because both LKB1 and COX-2 are involved in tumorigenesis and suppression of apoptosis, we wanted to determine if expression patterns of these two genes are related in PJPs and in carcinomas from PJS patients. Here we developed an antibody that specifically recognizes the LKB1 protein and examined the expression of LKB1 protein and COX-2 protein in Peutz Jeghers polyps by immunostaining. We found that COX-2 was overexpressed in most of the PJPs, whereas LKB1 exhibited heterogeneity in its expression patterns. There is a statistically significant correlation between immunostaining of COX-2 and LKB1. Materials and Methods Patients and Samples Peripheral blood samples and formalin-fixed, paraffinembedded sections of 28 PJPs and five carcinomas were obtained from 11 patients with PJS after each participant had signed release and informed consent documents. The histopathological diagnosis of PJPs and carcinomas was confirmed in all cases by a single pathologist. Consecutive 4 6- m tissue sections were cut from each tissue block for IHC analysis. DNA Extraction Ten ml of blood was drawn in Vacutainer tubes containing EDTA (Becton Dickinson Vacutainer System; Rutherford, NJ) from each study subject. DNA was isolated with an Applied Biosystems 341 Nucleic Acid Purification System (Applied Biosystems; Foster City, CA) according to the manufacturer s instructions. Mutation Analysis Nine exons and the adjacent intronic regions of the LKB1 gene were amplified for analysis of germline mutation. The primers used in PCR were the same as those reported previously (Jenne et al. 1998), except for the primers used for exon 1. The primer pair of DJ698F (5 -GGTCCCCGAG- GACGAAGTTGA-3 ) and STK11 exon 1R (5 -ATCAGG- TACTTGCCGATGAG-3 ) was used for the first part of exon 1, and the primer pair of STK11 exon438 1F (5 - TCATCTACCAGCCGCGCCGCAA-3 ) and DJ673R (5 - ACCATCAGCACCGTGACTGG-3 ) was used for the second part of exon 1. The PCR products were treated using a PCR product Pre-Sequencing Kit (USB; Cleveland, OH) and were sequenced in both directions with the PCR primers. Positive results were confirmed in the CLIA-certified laboratory of GeneDx (GeneDx; Gaithersburg, MD; genedx.com/). LKB1 Antibody Preparation Sigma Genosys (The Woodlands, TX) generated an antipeptide polyclonal antibody GN2733. The LKB1 peptide (KKKKLRRIPNGEAN) corresponding to the amino terminal region (AA81 AA94) of human and murine LKB1 was synthesized and conjugated to keyhole limpet hemocyanin before injection into rabbits. The sequence-specific antibodies were then affinity-purified from these antisera using peptide columns. We also studied an additional polyclonal antibody in the carboxyl terminus region of the LKB1 but could not reliably detect expression in normal colon mucosa or in PJPs by immunobiochemistry. Western Blotting Total protein (20 g) was analyzed by 10% SDS-PAGE and blotted according to standard protocols (Sambrook et al. 1989). GN2733 was used as primary antibody to detect the LKB1 protein in DiFi, a colon cancer cell line (Dolf et al. 1991) and in mouse pancreas tissue lysates by an ECL Western blotting analysis system (Amersham Pharmacia Biotech; Fair Lawn, NJ) Immunochemical Analysis Slides were deparaffinized and endogenous peroxidase activity was blocked by incubation in 3% H 2 O 2 for 10 min at room temperature. Sections were then placed in PBS and microwaved for 10 min for antigen retrieval. The anti-lkb1 antibody was applied at 1:500 dilution and incubated overnight at 4C. Immunodetection was performed with an LSAB 2 system (DAKO; Carpinteria, CA). Hematoxylin was used as a counterstain. A rabbit anti-lkb1 polyclonal antibody GN2733 generated against the 14 amino acid sequences at the N-terminus of LKB1 described above was used for the anti-lkb1 immunostaining at a dilution of 1:500. A mouse monoclonal antibody against human COX-2 (Cayman Chemical Catalog no ; Ann Arbor, MI) was used for anti-cox-2 immunostaining at a dilution of 1:1000. For every sample, immunostaining was repeated at least twice to confirm the results. Staining was graded for intensity as negative ( ), low ( ), intermediate ( ), or high ( ) by two independent observers (C. Wei and A. Rashid) and there were no major discrepancies between the two observers. Statistical Analysis We used Spearman correlation to evaluate joint staining of LKB1 and COX-2 in polyps and cancers (analyzed both jointly and separately). We also used analysis of variance to compare the levels of staining, contrasting cancers with pol-
3 Expression of LKB1 and COX yps and polyps in the small bowel to other sites. We used SAS (1999) version 8.1 for all analyses. Results Germline Mutation of the LKB1 Gene in Patients with PJS Mutation analysis was performed on DNA obtained from probands of nine unrelated PJS families (Table 1). Mutations were detected in all but one family. This later family was previously shown to display linkage to the LKB1 locus (Amos et al. 1997). Patients 1 and 7 had a mutation at a splice site, patients 3 and 4 had nonsense mutations, and patient 5 and 6 each had the same frameshift mutation. All of these mutations result in a truncated LKB1 protein. Patient 2 had a 12- bp in-frame deletion, and patient 8 had a single nucleotide mutation that did not affect the LKB1 protein sequence but which may create an alternate splice site in exon 8. In all, of the seven different mutations that we detected, five are novel. Expression Patterns of LKB1 in PJPs and Carcinomas from Patients with PJS To analyze the endogenous LKB1 protein in the PJPs and carcinomas, we generated a rabbit anti-peptide polyclonal antibody GN2733. After affinity- purification, this sequence-specific anti-lkb1 antibody specifically recognized the human and murine 53KDa LKB1 protein on Western blotting analysis (Figure 1). We performed anti-lkb1 immunostaining of normal human colon samples (Figure 2A), which were used as control specimens, as well as the 28 PJPs and five carcinomas from the above-mentioned 11 patients with PJS (summarized in Table 2). LKB1 was expressed in both the nucleus and cytoplasm of the epithelial cells and in stromal cells of the normal colon mucosa. In the epithelial cells of 23 polyps (Figure 2B) and five carcinomas (Figure 2C), LKB1 was expressed in both the cytoplasm and nucleus. This was indistinguishable Figure 1 Endogenous LKB1 protein detected in a Western blot probed with anti-lkb1 antibody GN2733. Lane 1 and Lane 2 contain human DiFi cell and mouse pancreas tissue lysates respectively. from the normal expression pattern except that, in most of these cells, LKB1 expression levels were elevated compared with those in the normal epithelial cells. In contrast, one PJP expressed LKB1 in the nucleus, without cytoplasmic staining (Figure 2D), and four PJPs demonstrated loss of nuclear and cytoplasmic staining in epithelial cells, although there was detectable LKB1 protein expression in the stromal cells (Figure 2E). Of note was heterogeneity of the staining pattern in PJPs from the same patients. For example, two PJPs from patient 4 had elevated LKB1 expression in both nucleus and cytoplasm of the epithelial cells, whereas the other two PJPs had loss of LKB1 expression. These results suggest that the IHC expression also depends on the somatic alteration of the polyps, although the germline status is the same. Expression Pattern of COX-2 Protein in PJPs and Carcinomas from Patients with PJS We also performed COX-2 IHC on normal colon samples, PJPs, and carcinomas from patients with PJS, using a mouse monoclonal anti-cox-2 antibody to assess COX-2 expression (summarized in Table 2). In Table 1 Germline mutation of the LKB1 gene in patients with Peutz Jeghers syndrome Patient No. Location Codon Mutation Predicted affected phenotype 1 Intron1 IVS a 1 1g a (A/g-A/a) Splice site error, exon 2 skip 2 Exon pb deletion C73F, codon deleted 3 Exon2 123 CAG TAG Gln to stop 4 Exon3 137 CAG TAG Gln to stop 5 Exon6 280 C insertion Frameshift, stop at codon Exon6 280 C insertion Frameshift, stop at codon Intron7 IVS a 7 978g c (g/c-c/c) Splice-site error, exon 8 skip 8 Exon8 347 GCG GCA A347A, introduces an alternate splice site 9 b No mutation detected 10 b 11 b a Intervening sequence. b Same family. No mutation detected No mutation detected
4 1668 Wei, Amos, Rashid, Sabripour, Nations, McGarrity, Frazier Figure 2 Representative results of LKB1 and COX-2 immunostaining of normal human colon samples and tissue samples from patients with Peutz Jeghers syndrome. The antibodies used were rabbit polyclonal anti-lkb1 antibody GN2733 and mouse monoclonal anti-cox-2 anti-
5 Expression of LKB1 and COX normal colon tissue specimens, COX-2 was undetectable in epithelial cells but there was some immunostaining in stromal cells (Figure 2A). In contrast, COX-2 was overexpressed in the cytoplasm of the epithelial cells in 23 PJPs (Figure 2B) and five carcinomas (Figure 2C). In the remaining five PJPs, COX-2 expression was absent (Figures 2D and 2E). We compared the results of anti-lkb1 and anti-cox-2 immunostaining and found that COX-2 staining corresponded to LKB1 staining. All these five PJPs without COX-2 staining showed loss of LKB1 expression in the cytoplasm and nucleus (Figure 2E) or in the cytoplasm only (Figure 2D). Statistical analysis of the expression of polyps and carcinomas listed in Table 2 showed a highly significant correlation in antibody expression. Over all the samples, the Spearman correlation between staining for cytoplasmic staining of LKB1 and COX-2 was For nuclear staining of LKB1 vs COX-2 the correlation was 0.91, and for nuclear vs cytoplasmic staining of LKB1 the correlation was All of these results are significant at p When the data were stratified by polyp vs carcinoma histology, the correlations remained over 90% for all comparisons and the correlation between cytoplasmic LKB1 staining and COX-2 staining in carcinomas was 100%. Analysis of variance showed no significant differences in antibody staining between carcinomas and polyps or between polyps of the small bowel and other locations. Discussion In this study we described the LKB1 expression patterns in PJPs and carcinomas from 11 patients with PJS. We found two predominant patterns of staining in the samples. In one there was both nuclear and cytoplasmic expression. In a second pattern there was loss of expression for LKB1. Most of the PJPs and all carcinomas showed expression in the epithelium. Both wild-type and in most cases truncated LKB1 protein contribute to the staining from the anti-lkb1 antibody GN2733 corresponding to the N-terminal of LKB1. It has also been reported that LKB1 was expressed in polyps from LKB1 / mice (Miyoshi et al. 2002; Rossi et al. 2002) and in the epithelium of polyps from PJS patients using in situ hybridization analysis (Rowan et al. 2000). Interestingly, we observed heterogeneity of the staining patterns in different PJPs Table 2 Summary of anti-lkb1 and anti-cox-2 immunostaining results of specimens from patients with Peutz Jeghers syndrome Specimen LKB1 expression COX-2 expression Patient No. No. Site Cytoplasm Nucleus Cytoplasm Peutz Jeghers polyps 1 1 Duodenum 2 2 Duodenum 4 3 Duodenum 4 Stomach 5 Colon 6 Rectum 5 7 Colon 8 Colon a 7 9 Stomach 8 10 Colon 11 Stomach 12 Stomach 13 Colon 9 14 Colon 15 Duodenum 16 Duodenum 17 Colon Duodenum 19 Duodenum 20 Duodenum 21 Colon 22 Small intestine 23 Colon 24 Rectum 25 Ileum 26 Small intestine 27 Colon Jejunum Carcinomas 3 29 Pancreas 5 8 Colon a 6 30 Chest wall b 31 Breast (right) b 32 Breast (left) b a Peutz Jeghers polyps associated with colon carcinoma. b Metastatic breast carcinoma in chest wall and bilateral intraductal breast carcinomas. from the same patient. LKB1 expression was detected in some polyps but not in others from the same patient, showing genetic heterogeneity in PJS. This heterogeneity may be due to differences in somatic alteration in the PJPs in these patients. Previous studies suggest genetic heterogeneity in PJS (Mehenni et al. 1997; Olschwang et al. 1998; Westerman et al. 1999; body. LKB1 and COX-2 were detected with DAB (brown) and nuclei were counterstained with hematoxylin. In normal colon tissue sample (A), LKB1 protein was detected in both cytoplasm and nucleus of epithelial cells, while COX-2 protein was undetectable in epithelial cells by immunostaining. Elevated LKB1 protein expression was detected in epithelial cells of PJP specimen 21 (B) and carcinomas in specimen 32 (C). The expression pattern was indistinguishable from that in normal tissue. Overexpression of COX-2 protein was also detected in cytoplasm of epithelial cells in these two samples. Nuclear expression of LKB1 was observed in epithelial cells of PJP in specimen 7 (D), while no COX-2 expression was observed in epithelial cells. Neither LKB1 nor COX-2 expression was detected in PJP specimen 4 (E). Original magnification 20.
6 1670 Wei, Amos, Rashid, Sabripour, Nations, McGarrity, Frazier Entius et al. 2001). Studies of hamartomatous polyps and carcinomas from patients with PJS have revealed somatic mutations or loss of heterozygosity (LOH) of the LKB1 gene, as well as other genetic alterations in the APC, K-ras, -catenin, and p53 genes (Miyaki et al. 2000; Entius et al. 2001). All these genetic changes may alter LKB1 expression at the IHC level. Loss of expression in two polyps from patient 4 and one polyp from patient 11 may suggest biallelic inactivation in PJPs. Considering that LOH has been observed in some cases but is not a consistent feature of these tumors (Miyaki et al. 2000; Entius et al. 2001), it is possible that biallelic inactivation of LKB1 is not necessarily required for polyp formation but that haploinsufficiency resulting from LKB1 heterozygosity is sufficient for polyp formation. Studies of mouse models have suggested that haploinsufficiency is sufficient for polyp formation, and our results in human tissues agree with this finding (Miyoshi et al. 2002; Rossi et al. 2002). Although we attempted to stain LKB1 with two different anti-lkb1 antibodies, only the N-terminal antibody GN2733 that we generated gave reliable staining. Of the patients studied, one patient had a splice-site mutation upstream of the epitope used by this antibody and still showed cytoplasmic and nuclear staining for LKB1. It remains possible that the mutated LKB1 is detected by antibody GN2733 in some of the patients studied, while the remaining wild-type protein has been deleted. We have identified seven types of germline mutations in eight patients with PJS from eight different families. According to Nezu et al. (1999), mutations that cause truncation of the LKB1 protein at amino acid 311 or before result in loss of kinase function. On this basis, four types of mutations found in families 1, 3, 4, 5, 6, and 7 resulted in disruption of the kinase domain and kinase deficiency. Tiainen et al. (2002) demonstrated that kinase-deficient LKB1 mutants predominantly display nuclear immunostaining. This correlation between loss of kinase activity and nuclear accumulation of LKB1 suggests that the cytoplasmic localization is required for kinase activity. Here, in 10 (77%) of 13 PJPs and in carcinoma samples from these six families, the LKB1 protein displayed a localization pattern indistinguishable from that in the normal tissue samples. Our results indicate two possible explanations for these findings. One possibility is that the subcellular localization of LKB1 may not be solely related to kinase activity. If so, we would have detected more nuclear staining in those subjects with mutations before amino acid 311. The second possibility is that biallelic inactivation due to LOH is not a common event in PJPs, and so the other allele for these PJPs also contributes to the pattern of staining seen. The nuclear localization pattern found for only specimen 9 from patient 7 is highly consistent with the inability of the mutant SL26 to retain cytoplasmic LKB1, as reported by Nezu et al. (1999). The SL26 mutation is a small in-frame deletion mutation that substitutes four amino acids (303IRQH), and was identified in a PJS patient reported by Hemminki et al. (1998). This small in-frame deletion disrupts the consensus sequence of the potential nuclear localization signal (NLS) (Robbins et al. 1991), which consists of the pattern of two basic residues followed by 10-residue spacer, and another basic region in which at least three of five residues were basic residues. The splice error detected in patient 7 will cause exon 8 deletion (starting from codon 308), which disrupts the same potential NLS in the SL26 mutation, presumably altering the subcellular distribution of the LKB1 protein so that it may accumulate in the nucleus only, although we know the status of only one of the LKB1 alleles. The other allele needs to be further investigated. We demonstrated that COX-2 was overexpressed in the epithelium of 85% (28/33) of the PJPs and carcinomas. This is a somewhat higher rate than the 70% (16/23) and 64% (7/11) recently reported in two smaller studies by Rossi et al. (2002) and McGarrity et al. (2003), respectively. By comparing the LKB1 and COX-2 immunostaining results, we found that the polyps that expressed LKB1 overexpressed COX-2, and the polyps that showed loss of LKB1 expression also showed lack of COX-2 expression. Our results indicate that COX-2 expression correlates strongly with LKB1 expression. An exception was the polyps from patient 7, where LKB1 protein was detected in the nucleus yet we failed to detect COX-2 expression. The regulatory mechanism of COX-2 overexpression in PJPs is unknown. A mouse model study (Rossi et al. 2002) suggested that the Ras/Raf-1/MEK/ERK signal transduction pathway is most likely to mediate COX-2 induction in murine LKB1 / polyposis. Further investigation to identify the physiological LKB1 substrates will facilitate a more comprehensive understanding of how LKB1 is involved in signaling pathways to mediate its role both in polyp formation and in COX-2 induction. It has been reported that increased levels of COX-2 in intestinal epithelial cells increased their adhesion and simultaneously decreased their response to certain apoptotic stimuli (Tsujii and DuBois 1995). Another study showed that SC-58125, a selective COX-2 inhibitor, suppressed the growth of HCA-7 cells that had high levels of COX-2 expression in culture and in tumor implants in nude mice, but had no effect on HCT-116 cells that lack COX-2 expression in culture or when they were implanted in nude mice (Sheng et al. 1997). Therefore, it is quite possible that the overexpression of COX-2 in PJPs and carcinoma samples will result in resistance to apoptosis, thus increasing the tumorigenic potential. Another report indicates
7 Expression of LKB1 and COX that LKB1 is involved in p53-dependent apoptosis and that loss of LKB1 function in PJS leads to a deficiency in apoptosis, which results in the formation of multiple polyps and the subsequent development of malignant tumors (Karuman et al. 2001). Our results of COX-2 overexpression in the majority of the PJ samples suggest that COX-2 may be involved in tumorigenesis in patients with PJS. In summary, our results demonstrate that COX-2 is overexpressed in polyps and carcinomas from patients with PJS. Treatment with selective COX-2 inhibitors, such as celecoxib and NSAIDs, has been shown to induce apoptosis in a variety of cancer cells, including those of the colon, stomach, and prostate. Therefore, the finding of overexpression of COX-2 in PJPs and carcinomas provides insight into the development of chemopreventive strategies for this disease. Acknowledgments Supported in part by a NIH Grant R03 (CA ), a NIH Cancer Center Support Grant CA16672, American Cancer Society Grant RPG CCE-3, and the Janis Davis Gordon Memorial Fellowship from the Division of Cancer Prevention at MD Anderson Cancer Center. We thank the patients and their families for their cooperation. We also thank Mariann Crapanzano for her editorial comments. Literature Cited Amos CI, Bali D, Thiel TJ, Anderson JP, Gourley I, Frazier ML, Lynch PM, et al. (1997) Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p. Cancer Res 57: Bardeesy N, Sinha M, Hezel AF, Signoretti S, Hathaway NA, Sharpless NS, Loda M, et al. (2002) Loss of the LKB1 tumor suppressor provokes intestinal polyposis but resistance to transformation. Nature 419: Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, Ahlquist DA, et al. (1998) Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128: Collins SP, Reoma JL, Gamm DM, Uhler MD (2000) LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by camp-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 345: Dolf G, Meyn RE, Curley D, Prather N, Story MD, Boman BM, Siciliano MJ, et al. (1991) Extrachromosomal amplification of the epidermal growth factor receptor gene in a human colon carcinoma cell line. Genes Chromosomes Cancer 3:48 54 Eberhart CE, DuBois RN (1995) Eicosanoids and the gastrointestinal tract. Gastroenterology 109: Entius MM, Keller JJ, Westerman AM, van Rees BP, van Velthuysen ML, de Goeij AF, Wilson JH, et al. (2001) Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome. J Clin Pathol 54: Foley TR, McGarrity TJ, Abt AR (1988) Peutz-Jeghers syndrome: a clinicopathologic survey of the Harrisburg family with a 49- year follow-up. Gastroenterology 95: Giardiello FM, Welsh SB, Hamilton SR (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316: Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, et al. (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391: Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM, Knuutila S, et al. (1997) Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nature Genet 15: Jeghers H, McKusick VA, Katz KH (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N Engl J Med 241: Jenne DE, Reimann H, Nezu J, Freidel W, Loff S, Jeschke R, Muller O, et al. (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nature Genet 18:38 43 Karuman P, Gozani O, Odze RD, Zhou XC, Zhu H, Shaw R, Brien TP, et al. (2001) The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 7: Marignani PA, Kanai F, Carpenter CL (2001) LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J Biol Chem 276: McGarrity TJ, Peiffer LP, Amos CI, Frazier ML, Ward MG, Howett MK (2003) Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz Jeghers syndrome. Am J Gastroenterol 98: Mehenni H, Blouin JL, Radhakrishna U, Bhardwaj SS, Bhardwaj K, Dixit VB, Richards KF, et al. (1997) Peutz Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4. Am J Hum Genet 61: Miyaki M, Iijima T, Hosono K, Ishii R, Yasuno M, Mori T, Toi M, et al. (2000) Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome. Cancer Res 60: Miyoshi H, Nakau M, Ishikawa T, Seldin MF, Oshima M, Taketo MM (2002) Gastrointestinal hamartomatous polyposis in LKB1 heterozygous knockout mice. Cancer Res 62: Nezu J, Oku A, Shimane M (1999) Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients. Biochem Biophys Res Commun 261: Olschwang S, Markie D, Seal S, Neale K, Philios R, Cottrell S, Ellis I, et al. (1998) Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet 35:42 44 Prescott SM, Fitzpatrick FA (2000) Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470:M69 78 Robbins J, Dilworth SM, Laskey RA, Dingwall C (1991) Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64: Rossi DJ, Ylikorkala A, Korsisaari N, Salovaara R, Luukko K, Launonen V, Henkemeyer M, et al. (2002) Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc Natl Acad Sci USA 99: Rowan A, Churchman M, Jefferey R, Hanby A, Poulsom R, Tomlinson I (2000) In situ analysis of LKB1/STK11 mrna expression in human normal tissues and tumours. J Pathol 192: Sapkota GP, Kieloch A, Lizcano JM, Lain S, Arthur JS, Williams MR, Morrice N, et al. (2001) Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(rsk) and camp-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell growth. J Biol Chem 276: Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. 2nd ed. Plainview, NY, Cold Spring Harbor Laboratory Press SAS Institute (1999) SAS OnlineDoc, Version 8. Cary, NC, SAS Institute Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morow J, Beauchamp RD, et al. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: Smith WL, Garavito M, Dewitt, DL (1996) Prostaglandin endoper-
8 1672 Wei, Amos, Rashid, Sabripour, Nations, McGarrity, Frazier oxide H synthases (cyclooxygenase)-1 and -2. J Biol Chem 271: Spigelman AD, Murday V, Phillips RKS (1989) Cancer and the Peutz-Jeghers syndrome. Gut 30: Tiainen M, Vaahtomeri K, Ylikorkala A, Makela TP (2002) Growth arrest by the LKB1 tumor suppressor: induction of p21(waf1/cip1). Hum Mol Genet 11: Tiainen M, Ylikorkala A, Makela TP (1999) Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci USA 96: Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: Westerman AM, Entius MM, Boor PP, Koole R, de Baar E, Offerhaus GJ, Lubinski J, et al. (1999) Novel mutations in the LKB1/STKII gene in Dutch Peutz-Jeghers families. Hum Mutat 13:
Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome
126 J Clin Pathol 2001;54:126 131 Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome M M Entius*, J J Keller*, A M Westerman, B P van Rees, M-L
More informationP eutz-jeghers syndrome (PJS) is a rare dominantly
327 ORIGINAL ARTICLE Genotype phenotype correlations in Peutz-Jeghers syndrome C I Amos, M B Keitheri-Cheteri, M Sabripour, C Wei, T J McGarrity, M F Seldin, L Nations, P M Lynch, H H Fidder, E Friedman,
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationMultiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer
Multiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer A Kuijper SS Preisler-Adams FD Rahusen JJP Gille E van der Wall PJ van Diest J Clin Pathol
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationPhospho-AKT Sampler Kit
Phospho-AKT Sampler Kit E 0 5 1 0 0 3 Kits Includes Cat. Quantity Application Reactivity Source Akt (Ab-473) Antibody E021054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit Akt (Phospho-Ser473) Antibody
More informationCANCER GENETICS PROVIDER SURVEY
Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded
More informationColonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern
Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit
More informationTITLE: The Role of hcdc4 as a Tumor Suppressor Gene in Genomic Instability Underlying Prostate Cancer
AD Award Number: TITLE: The Role of hcdc4 as a Tumor Suppressor Gene in Genomic Instability Underlying Prostate Cancer PRINCIPAL INVESTIGATOR: Audrey van Drogen, Ph.D. CONTRACTING ORGANIZATION: Sidney
More informationSupporting Information
Supporting Information Fujishita et al. 10.1073/pnas.0800041105 SI Text Polyp Scoring. Intestinal polyps were counted as described (1). Briefly, the small and large intestines were excised, washed with
More informationBio 111 Study Guide Chapter 17 From Gene to Protein
Bio 111 Study Guide Chapter 17 From Gene to Protein BEFORE CLASS: Reading: Read the introduction on p. 333, skip the beginning of Concept 17.1 from p. 334 to the bottom of the first column on p. 336, and
More informationTHE STUDY ON RELATIONSHIP BETWEEN CIGARETTE SMOKING AND THE p53 PROTEIN AND P21 PROTEIN EXPRESSION IN NON-SMALL LUNG CANCER
( Thmese Journal of ('ancer Research 8(3): 187-19L 1996. THE STUDY ON RELATIONSHIP BETWEEN CIGARETTE SMOKING AND THE p53 PROTEIN AND P21 PROTEIN EXPRESSION IN NON-SMALL LUNG CANCER ZhouBaosen )~j'#:~ lleanguang
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationRAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.
۱ RAS Genes The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. Oncogenic ras genes in human cells include H ras, N ras,
More informationQuantification of early stage lesions for loss of p53 should be shown in the main figures.
Reviewer #1 (Remarks to the Author): Expert in prostate cancer The manuscript "Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers" uses a number of novel genetically engineered
More informationFamilial Adenomatous Polyposis
Familial Adenomatous Polyposis 1 in 10,000 incidence 100 s to 1000 s of colonic adenomas by teens Cancer risk: colon, gastric, duodenum (periampulla), small bowel, pancreas, papillary thyroid, childhood
More informationInsulin Resistance. Biol 405 Molecular Medicine
Insulin Resistance Biol 405 Molecular Medicine Insulin resistance: a subnormal biological response to insulin. Defects of either insulin secretion or insulin action can cause diabetes mellitus. Insulin-dependent
More informationComputational Systems Biology: Biology X
Bud Mishra Room 1002, 715 Broadway, Courant Institute, NYU, New York, USA L#4:(October-0-4-2010) Cancer and Signals 1 2 1 2 Evidence in Favor Somatic mutations, Aneuploidy, Copy-number changes and LOH
More informationC-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is
' ^Summary C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein pigment isolated from Spirulina platensis. This water- soluble protein pigment is of greater importance because of its various
More informationClonal evolution of human cancers
Clonal evolution of human cancers -Pathology-based microdissection and genetic analysis precisely demonstrates molecular evolution of neoplastic clones- Hiroaki Fujii, MD Ageo Medical Laboratories, Yashio
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationSuppression of Peutz Jeghers Polyposis by Inhibition of Cyclooxygenase-2
GASTROENTEROLOGY 2004;127:1030 1037 RAPID COMMUNICATION Suppression of Peutz Jeghers Polyposis by Inhibition of Cyclooxygenase-2 LINA UDD,*, PEKKA KATAJISTO,*, DERRICK J. ROSSI,* ANNA LEPISTÖ, ANNA MARIA
More informationPathology perspective of colonic polyposis syndromes
Pathology perspective of colonic polyposis syndromes When are too many polyps too many? David Schaeffer Head and Consultant Pathologist, Department of Pathology and Laboratory Medicine, Vancouver General
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationColonic Polyp. Najmeh Aletaha. MD
Colonic Polyp Najmeh Aletaha. MD 1 Polyps & classification 2 Colorectal cancer risk factors 3 Pathogenesis 4 Surveillance polyp of the colon refers to a protuberance into the lumen above the surrounding
More informationTUMOR-SUPPRESSOR GENES. Molecular Oncology Michael Lea
TUMOR-SUPPRESSOR GENES Molecular Oncology 2011 Michael Lea TUMOR-SUPPRESSOR GENES - Lecture Outline 1. Summary of tumor suppressor genes 2. P53 3. Rb 4. BRCA1 and 2 5. APC and DCC 6. PTEN and PPA2 7. LKB1
More informationImmunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis
Virchows Arch (2009) 454:25 29 DOI 10.1007/s00428-008-0701-y ORIGINAL ARTICLE Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis Rachel S.
More informationMutations and Aberrant Transcriptions of Stk11 (Lkb1) Gene in Rat Liver Tumors
Mutations and Aberrant Transcriptions of Stk11 (Lkb1) Gene in Rat Liver Tumors NAOKO WAKABAYASHI 1, KYOKO OKABE 1, MAI HAYASHI 1, KANYA HONOKI 2 and TOSHIFUMI TSUJIUCHI 1 1 Division of Cancer Biology and
More informationMichele Bettinelli RN Maria Scholz RN Sandra Scolaro RN
Michele Bettinelli RN Maria Scholz RN Sandra Scolaro RN Objectives Define Peutz-Jeghers Syndrome (PJS) Describe the management and treatment of PJS Discuss the patient experience associated with the diagnosis
More informationAssessment performed on Tuesday, July 29, 2014, at Lions Gate Hospital, North Vancouver
Assessors report for ciqc Run 37: BRAF V600E (April 2014) Assessors: B Gilks, R Wolber, K Ung, P Tavassoli, J Garratt and J Won (recorder) Assessment performed on Tuesday, July 29, 2014, at Lions Gate
More informationNeoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath
Neoplasia 18 lecture 6 Dr Heyam Awad MD, FRCPath ILOS 1. understand the role of TGF beta, contact inhibition and APC in tumorigenesis. 2. implement the above knowledge in understanding histopathology reports.
More informationProblem Set 8 Key 1 of 8
7.06 2003 Problem Set 8 Key 1 of 8 7.06 2003 Problem Set 8 Key 1. As a bright MD/PhD, you are interested in questions about the control of cell number in the body. Recently, you've seen three patients
More informationIntroduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.
Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)
More informationCancer genetics
Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1
More informationMDJ The Role of K-Ras and PI3Kcb Expression in Oral Vol.:10 No.:2 2013
MDJ The Role of K-Ras and PI3Kcb Expression in Oral Squamous Cell Carcinoma Dr. Asseel Mohammed ghazi. B.D.S Dr.Muna S. Merza. B.D.S, M.Sc. Ph.D Abstract Background: Oral squamous cell carcinoma is an
More informationA class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.
Tumor Suppressor Genes A class of genes that normally suppress cell proliferation. p53 and Rb..ect Mutations that inactivate the tumor suppressor gene products can release cells from growth suppression
More informationRelative Frequency and Morphology of Cancers in STK11 Mutation Carriers
GASTROENTEROLOGY 2004;126:1788 1794 Relative Frequency and Morphology of Cancers in STK11 Mutation Carriers WENDY LIM,* SYLVIANE OLSCHWANG, JOSBERT J. KELLER, ANNE MARIE WESTERMAN, FRED H. MENKO, LISA
More information27
26 27 28 29 30 31 32 33 34 35 Diagnosis:? Diagnosis: Juvenile Polyposis with BMPR1A Mutation 36 Juvenile Polyposis Syndrome Rare Autosomal Dominant Disorder with Multiple Juvenile Polyps in GI Tract Juvenile
More informationP eutz-jeghers Syndrome (PJS) is a rare autosomal
1091 ORIGINAL ARTICLE STRAD in Peutz-Jeghers syndrome and sporadic cancers W W J de Leng, J J Keller, S Luiten, A R Musler, M Jansen, A F Baas, F W M de Rooij, J J P Gille, F H Menko, G J A Offerhaus,
More informationBIO360 Fall 2013 Quiz 1
BIO360 Fall 2013 Quiz 1 1. Examine the diagram below. There are two homologous copies of chromosome one and the allele of YFG carried on the light gray chromosome has undergone a loss-of-function mutation.
More information609G: Concepts of Cancer Genetics and Treatments (3 credits)
Master of Chemical and Life Sciences Program College of Computer, Mathematical, and Natural Sciences 609G: Concepts of Cancer Genetics and Treatments (3 credits) Text books: Principles of Cancer Genetics,
More informationCancer risk in patients with Peutz Jeghers syndrome: A retrospective cohort study of 336 cases
705131TUB0010.1177/1010428317705131Tumor BiologyChen et al. research-article2017 Original Article Cancer risk in patients with Peutz Jeghers syndrome: A retrospective cohort study of 336 cases Tumor Biology
More informationsequences of a styx mutant reveals a T to A transversion in the donor splice site of intron 5
sfigure 1 Styx mutant mice recapitulate the phenotype of SHIP -/- mice. (A) Analysis of the genomic sequences of a styx mutant reveals a T to A transversion in the donor splice site of intron 5 (GTAAC
More informationBASIC LIVER, PANCREAS, AND BILIARY TRACT
GASTROENTEROLOGY 2010;139:586 597 BASIC LIVER, BILIARY TRACT LKB1 Haploinsufficiency Cooperates With Kras to Promote Pancreatic Cancer Through Suppression of p21-dependent Growth Arrest JENNIFER P. MORTON,*,
More informationGI EMERGENCIES Acute Abdominal Pain
GI EMERGENCIES Acute Abdominal Pain Marcia Cruz-Correa, MD, PhD, AGAF. FASGE Associate Professor of Medicine, Biochemistry, Surgery Director Translational Research University of Puerto Rico Comprehensive
More informationChapter 4. Cyclooxygenase expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas
Chapter 4 Cyclooxygenase expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas WWJ de Leng 1, AM Westerman 2, MAJ Weterman 1, FWM de Rooij 2, H van Dekken 3, AFPM de Goeij 4,
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationYES NO UNKNOWN. Stage I: Rule-Out Dashboard ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above)
Stage I: Rule-Out Dashboard GENE/GENE PANEL: SMAD4, BMPR1A DISORDER: Juvenile Polyposis Syndrome HGNC ID: 6670, 1076 OMIM ID: 174900, 175050 ACTIONABILITY PENETRANCE 1. Is there a qualifying resource,
More informationMEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)
Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More informationDifferential localisation of hamartin and tuberin and increased S6 phosphorylation in a tuber
Differential localisation of hamartin and tuberin in a tuber 10 Differential localisation of hamartin and tuberin and increased S6 phosphorylation in a tuber Floor Jansen*, Robbert Notenboom*, Mark Nellist*,
More informationStudying The Role Of DNA Mismatch Repair In Brain Cancer Malignancy
Kavya Puchhalapalli CALS Honors Project Report Spring 2017 Studying The Role Of DNA Mismatch Repair In Brain Cancer Malignancy Abstract Malignant brain tumors including medulloblastomas and primitive neuroectodermal
More informationDevelopment of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More informationmicrorna Presented for: Presented by: Date:
microrna Presented for: Presented by: Date: 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions
More informationSupplementary data Supplementary Figure 1 Supplementary Figure 2
Supplementary data Supplementary Figure 1 SPHK1 sirna increases RANKL-induced osteoclastogenesis in RAW264.7 cell culture. (A) RAW264.7 cells were transfected with oligocassettes containing SPHK1 sirna
More informationGrowth and Differentiation Phosphorylation Sampler Kit
Growth and Differentiation Phosphorylation Sampler Kit E 0 5 1 0 1 4 Kits Includes Cat. Quantity Application Reactivity Source Akt (Phospho-Ser473) E011054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/22278 holds various files of this Leiden University dissertation. Author: Cunha Carvalho de Miranda, Noel Filipe da Title: Mismatch repair and MUTYH deficient
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationOncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber
Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber jweber@dom.wustl.edu Oncogenes & Cancer DNA Tumor Viruses Simian Virus 40 p300 prb p53 Large T Antigen Human Adenovirus p300 E1A
More informationAssessment Run B HER-2 IHC. HER-2/chr17 ratio**
Assessment Run B2 20 HER-2 IHC Material The slide to be stained for HER-2 comprised the following 5 tissues: IHC HER-2 Score* (0, +, 2+,3+) FISH HER-2/chr7 ratio**. Breast ductal carcinoma 0..3 2. Breast
More informationMUTATIONS, MUTAGENESIS, AND CARCINOGENESIS. (Start your clickers)
MUTATIONS, MUTAGENESIS, AND CARCINOGENESIS (Start your clickers) How do mutations arise? And how do they affect a cell and its organism? Mutations: heritable changes in genes Mutations occur in DNA But
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationCDH1 truncating alterations were detected in all six plasmacytoid-variant bladder tumors analyzed by whole-exome sequencing.
Supplementary Figure 1 CDH1 truncating alterations were detected in all six plasmacytoid-variant bladder tumors analyzed by whole-exome sequencing. Whole-exome sequencing of six plasmacytoid-variant bladder
More informationMuscular Dystrophy. Biol 405 Molecular Medicine
Muscular Dystrophy Biol 405 Molecular Medicine Duchenne muscular dystrophy Duchenne muscular dystrophy is a neuromuscular disease that occurs in ~ 1/3,500 male births. The disease causes developmental
More informationLack of STK11 Gene Expression in Homozygous Twins with Peutz-Jeghers Syndrome
154 Annals of Clinical & Laboratory Science, vol. 34, no. 2, 2004 Lack of STK11 Gene Expression in Homozygous Twins with Peutz-Jeghers Syndrome Chih-Jen Tseng, 1 Shi-Feng Chen, 2 Shu-I Liou, 2 Shu-Chuan
More informationSection D: The Molecular Biology of Cancer
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Section D: The Molecular Biology of Cancer 1. Cancer results from genetic changes that affect the cell cycle 2. Oncogene proteins and faulty
More informationMolecular and genetic analysis of stromal fibroblasts in prostate cancer
Final report ESMO Translational Research Fellowship 2010-2011 Molecular and genetic analysis of stromal fibroblasts in prostate cancer Michalis Karamouzis Host Institute Department of Biological Chemistry,
More informationBihong Zhao, M.D, Ph.D Department of Pathology
Bihong Zhao, M.D, Ph.D Department of Pathology 04-28-2009 Is tumor self or non-self? How are tumor antigens generated? What are they? How does immune system respond? Introduction Tumor Antigens/Categories
More informationAP VP DLP H&E. p-akt DLP
A B AP VP DLP H&E AP AP VP DLP p-akt wild-type prostate PTEN-null prostate Supplementary Fig. 1. Targeted deletion of PTEN in prostate epithelium resulted in HG-PIN in all three lobes. (A) The anatomy
More informationp53 expression in invasive pancreatic adenocarcinoma and precursor lesions
Malaysian J Pathol 2011; 33(2) : 89 94 ORIGINAL ARTICLE p53 expression in invasive pancreatic adenocarcinoma and precursor lesions NORFADZILAH MY MBBCH,* Jayalakshmi PAILOOR MPath, FRCPath,* RETNESWARI
More informationEstrogen receptor (ER)
Material The slide to be stained for ER comprised: Assessment Run B26 2018 Estrogen receptor (ER) No. Tissue ER-positivity* ER-intensity* 1. Uterine cervix 80-90% Moderate to strong 2. Tonsil 1-5% Weak
More informationSupplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells
Supplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells (b). TRIM33 was immunoprecipitated, and the amount of
More informationHands-On Ten The BRCA1 Gene and Protein
Hands-On Ten The BRCA1 Gene and Protein Objective: To review transcription, translation, reading frames, mutations, and reading files from GenBank, and to review some of the bioinformatics tools, such
More informationIntroduction to Cancer Biology
Introduction to Cancer Biology Robin Hesketh Multiple choice questions (choose the one correct answer from the five choices) Which ONE of the following is a tumour suppressor? a. AKT b. APC c. BCL2 d.
More informationCell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-
Supplemental material and methods Reagents. Hydralazine was purchased from Sigma-Aldrich. Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC- 133, human thyroid medullary
More informationThe functional investigation of the interaction between TATA-associated factor 3 (TAF3) and p53 protein
THESIS BOOK The functional investigation of the interaction between TATA-associated factor 3 (TAF3) and p53 protein Orsolya Buzás-Bereczki Supervisors: Dr. Éva Bálint Dr. Imre Miklós Boros University of
More informationSupplementary Figure 1. AdipoR1 silencing and overexpression controls. (a) Representative blots (upper and lower panels) showing the AdipoR1 protein
Supplementary Figure 1. AdipoR1 silencing and overexpression controls. (a) Representative blots (upper and lower panels) showing the AdipoR1 protein content relative to GAPDH in two independent experiments.
More informationThe Biology and Genetics of Cells and Organisms The Biology of Cancer
The Biology and Genetics of Cells and Organisms The Biology of Cancer Mendel and Genetics How many distinct genes are present in the genomes of mammals? - 21,000 for human. - Genetic information is carried
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationSmoke Like a Man, Survive Like a Woman
Smoke Like a Man, Survive Like a Woman Sex Specific Differences in Lung Cancer Pulmonary Grand Rounds Philippe R. Montgrain, M.D. May 1, 2008 Objectives 1. Review how lung cancer differs in men and women.
More information7/6/2015. Cancer Related Deaths: United States. Management of NSCLC TODAY. Emerging mutations as predictive biomarkers in lung cancer: Overview
Emerging mutations as predictive biomarkers in lung cancer: Overview Kirtee Raparia, MD Assistant Professor of Pathology Cancer Related Deaths: United States Men Lung and bronchus 28% Prostate 10% Colon
More informationFGL2 A new biomarker for cancer in a simple blood test
FGL2 A new biomarker for cancer in a simple blood test WHO IS FGL2 Human gene (chromosome 7) is 7 kb long, 2 exons, monomer protein 70 KD, tetramer in solution. Fibrinogen-like protein 2 (Fgl2), a member
More informationSALSA MLPA probemix P315-B1 EGFR
SALSA MLPA probemix P315-B1 EGFR Lot B1-0215 and B1-0112. As compared to the previous A1 version (lot 0208), two mutation-specific probes for the EGFR mutations L858R and T709M as well as one additional
More informationAntibodies for Unfolded Protein Response
Novus-lu-2945 Antibodies for Unfolded rotein Response Unfolded roteins ER lumen GR78 IRE-1 GR78 ERK Cytosol GR78 TRAF2 ASK1 JNK Activator Intron RIDD elf2α Degraded mrna XB1 mrna Translation XB1-S (p50)
More informationTITLE: A Mouse Model to Investigate the Role of DBC2 in Breast Cancer
AD Award Number: W81XWH-04-1-0325 TITLE: A Mouse Model to Investigate the Role of DBC2 in Breast Cancer PRINCIPAL INVESTIGATOR: Valerie Boka CONTRACTING ORGANIZATION: University of Texas Health Science
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION doi:10.1038/nature11429 S1a 6 7 8 9 Nlrc4 allele S1b Nlrc4 +/+ Nlrc4 +/F Nlrc4 F/F 9 Targeting construct 422 bp 273 bp FRT-neo-gb-PGK-FRT 3x.STOP S1c Nlrc4 +/+ Nlrc4 F/F casp1
More informationAssessment Run C1 2017
Assessment Run C1 2017 PD-L1 The first assessment in this new NordiQC Companion module C1 focused on the accuracy of the PD-L1 IHC assays performed by the participating laboratories to identify patients
More informationAssessment of Correlation between Cyclo oxygen ase-2 Expression and Clinicopathological Features of Colorectal Carcinoma
Med. J. Cairo Univ., Vol. 84, No. 1, September: 1029-1035, 2016 www.medicaljournalofcairouniversity.net Assessment of Correlation between Cyclo oxygen ase-2 Expression and Clinicopathological Features
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationnumber Done by Corrected by Doctor Maha Shomaf
number 19 Done by Waseem Abo-Obeida Corrected by Abdullah Zreiqat Doctor Maha Shomaf Carcinogenesis: the molecular basis of cancer. Non-lethal genetic damage lies at the heart of carcinogenesis and leads
More informationAssessment Run B HER2 IHC
Assessment Run B24 2017 HER2 IHC Material The slide to be stained for HER2 comprised the following 5 materials: IHC: HER2 Score* (0, 1+, 2+, 3+) FISH: HER2 gene/chr 17 ratio** 1. Breast carcinoma, no.
More informationSupplementary Information Supplementary Fig. 1. Elevated Usp9x in melanoma and NRAS mutant melanoma cells are dependent on NRAS for 3D growth.
Supplementary Information Supplementary Fig. 1. Elevated Usp9x in melanoma and NRAS mutant melanoma cells are dependent on NRAS for 3D growth. a. Immunoblot for Usp9x protein in NRAS mutant melanoma cells
More informationMUTATIONS, MUTAGENESIS, AND CARCINOGENESIS
MUTATIONS, MUTAGENESIS, AND CARCINOGENESIS How do different alleles arise? ( allele : form of a gene; specific base sequence at a site on DNA) Mutations: heritable changes in genes Mutations occur in DNA
More informationDETERMINATION OF K-RAS MUTATION IN COLORECTAL AND LUNG CANCER
665 J App Pharm 03(04): 655-669; October, 2012 Andreas et al., 2012 Short Communication DETERMINATION OF K-RAS MUTATION IN COLORECTAL AND LUNG CANCER E.Andreas 1,2,3, Ali Mujahid 1,3, Attia Youssef 1,
More informationAccumulated Clonal Genetic Alterations in Familial and Sporadic Colorectal Carcinomas with Widespread Instability in Microsatellite Sequences
American Journal of Pathology, Vol. 153, No. 4, October 1998 Copyright American Society for Investigative Pathology Accumulated Clonal Genetic Alterations in Familial and Sporadic Colorectal Carcinomas
More informationResult Navigator. Positive Test Result: STK11. After a positive test result, there can be many questions about what to do next. Navigate Your Results
Result Navigator Positive Test Result: STK11 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life
More information